Reflections on melatonin: Focus on child mental health

Psychiatric Bulletin

Volumn 32, Issue 12, 2008, Pages 444-448

  Famuyiwa, Oluwole O ^a,b   Adewuya, Abiodun O ^c  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; AUTISM; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED RELEASE FORMULATION; DISEASE EXACERBATION; DRUG CAPSULE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EPILEPTIFORM SEIZURE; HUMAN; INSOMNIA; LOZENGE; MENTAL HEALTH CARE; SEIZURE; SIDE EFFECT; TABLET; TREATMENT RESPONSE;

EID: 57649179732     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.bp.107.017889     Document Type: Article

References (37)

1. AMERICAN SLEEP DISORDERS ASSOCIATION (1997) The International Classification of Sleep Disorders. Revised: Diagnostic and Coding Manual. American Sleep Disorders Association.
2. ARMOUR, D. & PATON, C. (2004) Melatonin in the treatment of insomnia in children and adolescents. Psychiatric Bulletin, 28, 222-224.
3. ARMSTRONG, S. M. (1989) Melatonin and circadian control in mammals. Experientia, 45, 932.
4. BARKLEY, R. A., McMURRAY, M. B., EDELBROCK, C. S., et al (1990) Side-effects of methyiphenidate in children with attention hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics, 86, 184-192.
5. BARTNESS, T. J. & GOLDMAN, B. D. (1989) Mammalian plneal melatonin. A clock for all seasons. Experientia, 45, 939-945.
6. BESEDOVSKY, H. O. & REY, A. D. (1996) Immuno-neuro-endocrine interactions: facts and hypotheses. Endocrinology Review, 17, 64.
7. BRZEZINSKI, A. (1997) Mechanisms of disease: melatonin in humans. New England Journal of Medicine, 336, 186-195.
8. BUSCEMI, N., VANDERMEER, B., HOOTON, N., et al (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restrictions: meta-analysis. British Medical Journal, 332, 385-393.
9. CAMFIELD, P., GORDON, K., DOOLEY, J., et al (1996) Melatonin appears ineffective in children with intellectual deficits and fragmented sleep. Journal of Child Neurology, 11, 341-343.
10. COPPOLA, G., IERVOLINO, G., MASTROSIMONE, M., et al (2004) Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Brain and Development, 26, 373-376.
11. GIANNOTTI, F., CORTESI, F., CERQUIGLIN, A., et al (2006) An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. Journal of Autism and Developmental Disorders, 36, 741-752.
12. GOLAN, N., SHARSHAR, E., RAVID, S., et al (2004) Sleep disorders and daytime sleepiness in children with attention deficit hyperactivity disorder. Sleep, 27, 261-266.
13. HERXHEIMER, A. & PETRIE, K. J. (2002) Melatonin for the prevention and treatment of jet lag. Cochrane Database Systemic Review, 2, CD001520.
14. JAN, M. M. (2000) Melatonin for the treatment of handicapped children with severe sleep disorders. Pediatric Neurology, 23, 229-232.
15. LACKS, P. & ROTERTS, M. (1986) Knowledge and practice of sleep hygiene techniques in insomnia and good sleepers. Behaviour Research and Therapy, 24, 365-368.
16. LAMBERG, L. (1996) Melatonin potentially useful but safety, efficacy remain uncertain. JAMA, 276, 1011-1014.
17. MOLLER, M., RAVAULT, J. P. & COZZI, B. (1996) The chemical: neuropeptides. Neurochemistry International, 28, 23-33.
18. MORIN, C. M., CULBERT, J. P. & SCHWARTZ, S. M. (1994) Non-pharmacological interventions for insomnia. A meta-analysis of treatment efficacy. American Journal of Psychiatry, 151, 1172-1180.
19. NAGTEGAAL, J. E., LAURANT, G. A., KERKI-IOF, M. G., et al (2000) Effects of melatonin on the quality of life in patients with delayed sleep-phase syndrome. Journal of Psychosomatic Research, 48, 45-50.
20. OWENS, J. A., ROSEN, C. L. & MINDELL, J. A. (2003) Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics, 111, 628-635.
21. PESELOW, E. D. (2005) Biological therapies. In Kaplan & Sadock's Comprehensive Textbook of Psychiatry, Vol. 2 (8th edn), (eds H. I. Kaplan & V. A. Sadock), p. 2996. Lippincott, Williams & Wilkins.
22. PHILLIPS, L. & APPLETON, R. E. (2004) Systematic review of melatonin treatment in children with neuro-developmental disabilities and sleep impairment. Developmental Medicine and Child Neurology, 46, 771-775.
23. PIERIE, C., MARRA, M., MORONI, F., et al (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sciences, 55, 271-276.
24. RUSAK, B. & BINA, K. G. (1990) Neurotransmitters in the mammalian circadian system. Annual Review Neuroscience, 13, 387.
25. SAJITH, S. G. & CLARKE, D. (2007) Melatonin and sleep disorders associated with intellectual disability. A clinical review. Journal of Intellectual Disability Research, 51, 2-13.
26. SCHWARTZ, G., AMOR, L. B., GRIZENKO, N., et al (2004) Actigraphic monitoring during sleep of children with ADHD on methyiphenidate and placebo. Journal of American Academy of Child and Adolescent Psychiatry, 43, 1276-1282.
27. SHELDON, S. H. (1998) Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet, 351, 1254.
28. SMITS, M. G., VAN STEL, H. F., VAN DER HEIJDEN, K., et al (2003) Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. Journal of American Child and Adolescent Psychiatry, 42, 1286-1293.
29. SUTHERLAND, E. R., MARTIN, R. J., ELLISON, M. C., et al (2003) Elevated serum melatonin is associated with the nocturnal worsening of asthma. Journal of Allergy and Clinical Immunology, 112, 513-517.
30. SZEINBERG, A., BORODKIN, K. & DAGAN, Y. (2006) Melatonin treatment in adolescents with delayed sleep phase syndrome. Clinical Pediatrics, 45, 809-818.
31. TJON PLANfsI, C. V., BROERREN, J. P., STRARREVELD, J. S., et al (2003) Melatonin for treatment of sleeping disorders in children with attention deficit hyperactivity disorder: a preliminary open label study. European Journal of Pediatrics, 162, 554-555.
32. VAN DER HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J., et al (2007) Effect of melatonin on sleep, behaviour and cognition in ADHD and chronic sleep-onset, insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 233-241.
33. WALDRON, D. L., BRAMBLE, D. & GRINGAS, P. (2005) Melatonin: prescribing practices and adverse events. Archives of Diseases in Childhood, 90, 1206-1207.
34. WEAVER, D. R. (1997) Reproductive safety of melatonin: a 'wonder drug' to wonder about. Journal of Biological Rhythms, 12, 682-689.
35. WEBB, S. M. & PUIG-DOMINGO, M. (1995) Role of melatonin in health and diseases. Clinical Endocrinology, 42, 221-234.
36. WEISS, M. D.,WASDELL, M. B., BOMBEN, M. M., et al (2006): Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 512-519.
37. ZHDANOVA, I. V., WURTMAN, R. J., LYNCH, H. J., et al (1995) Sleep inducing effects of low doses of melatonin ingested in the evening. Clinical Pharmacology and Therapeutics, 57, 552-558.